Novartis Ag (NVSEF) Net Income towards Common Stockholders Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Net Income towards Common Stockholders Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 14.64%
Jun 30, 2024 -3.92%
Dec 31, 2023 56.23%
Sep 30, 2023 24.31%
Jun 30, 2023 2.83%
Mar 31, 2023 19.95%
Dec 31, 2022 -21.70%
Sep 30, 2022 -16.03%
Jun 30, 2022 -2.48%
Mar 31, 2022 2.61%
Dec 31, 2021 -5.01%
Sep 30, 2021 3.99%
Jun 30, 2021 44.32%
Mar 31, 2021 22.68%
Dec 31, 2020 376.42%
Sep 30, 2020 48.73%
Jun 30, 2020 4,076.73%
Mar 31, 2020 1,201.75%
Jun 30, 2019 3,108.32%
Mar 31, 2019 -1,044.65%